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Abstract
Following a request from the European Commission, the Panel on Additives and Products or Substances
used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on an essential oil from
Origanum vulgare subsp. hirtum var Vulkan (DOS 00001) when used as a sensory feed additive for all
animal species. Analysis of the oil identiﬁed 34 components accounting for > 99% of the oil, with
carvacrol being the most prevalent (> 60%). Five tolerance studies in three species (chickens for
fattening, weaned piglets and dairy cows) were made to assess the safety for the target species. The
recommended use level of 150 mg additive/kg feed was shown to be safe for chickens for fattening and
weaned piglets and this conclusion is extended to all poultry and porcine species grown for meat
production. A dose of 500 mg additive/head and day (equivalent to ~ 25 mg/kg complete feed) was also
demonstrated safe for the dairy cow. The Panel concluded that since the recommended use level differs
between the dairy cow and the non-ruminants tested the lower use level of 25 mg additive/kg feed could
be applied to all target animals not included above. Residue studies (meat, liver, fat milk and eggs)
showed that the exposure of consumers to products from animals given the additive at the recommended
use level did not raise safety concerns. The additive should be considered as an irritant to skin and eyes,
and to have a potential for sensitisation of susceptible individuals. Use in animal production of the
essential oil extracted from O. vulgare is not expected to pose a risk for the environment. Since oregano
and its extracts is recognised to ﬂavour food and its function in feed would be essentially the same as that
in food, no further demonstration of efﬁcacy is considered necessary.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from the company Dostofarm GmbH2 for authorisation
of the product natural essential oil from Origanum vulgare L. subsp. hirtum var. Vulkan (DOS 00001),
when used as a feed additive for all animal species (category: sensory additives; functional group:
ﬂavourings).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 14 March 2016.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product natural essential oil from O. vulgare L. subsp. hirtum var. Vulkan (DOS 00001), when used
under the proposed conditions of use (see Section 3.2.4).
1.2. Additional information
Oregano oil from O. vulgare L. is currently authorised as a feed additive according to the entry in
the European Union Register of Feed Additives pursuant to Regulation (EC) No 1831/2003 (2b natural
products – botanically deﬁned).
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier3 in support of the authorisation request for the use of an essential oil from O. vulgare L.
subsp. hirtum var. Vulkan (DOS 00001) as a feed additive. The technical dossier was prepared
following the provisions of Article 7 of Regulation (EC) No 1831/2003, Regulation (EC) No 429/20084
and the applicable EFSA guidance documents.
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) used the data
provided by the applicant together with data from other sources, such as previous risk assessments by
EFSA or other expert bodies, peer-reviewed scientiﬁc papers, other scientiﬁc reports and experts’
knowledge, to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the oregano essential oil in animal feed. The Executive Summary of
the EURL report can be found in Annex A.5
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of
Origanum vulgare L. subsp. hirtum is in line with the principles laid down in Regulation (EC) No 429/2008
and the relevant guidance documents: Guidance on safety assessment of botanicals and botanical
preparations intended for use as ingredients in food supplements (EFSA Scientiﬁc Committee, 2009),
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Saqual GmbH on behalf of Dostofarm GmbH, Klosterstrasse 39, 5430 Wettingen, Switzerland.
3 FEED dossier reference: FAD-2016-0004.
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
5 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/files/FinRep-FAD-2016-0004.pdf
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Compendium of botanicals reported to contain naturally occurring substances of possible concern for
human health when used in food and food supplements (EFSA, 2012), Guidance for the preparation of
dossiers for sensory additives (EFSA FEEDAP Panel, 2012a), Technical guidance: Tolerance and efﬁcacy
studies in target animals (EFSA FEEDAP Panel, 2011), Technical Guidance for assessing the safety of feed
additives for the environment (EFSA, 2008a), Guidance for the preparation of dossiers for additives
already authorised for use in food (EFSA FEEDAP Panel, 2012b), Guidance for establishing the safety of
additives for the consumer (EFSA FEEDAP Panel, 2012c), Guidance on studies concerning the safety
of use of the additive for users/workers (EFSA FEEDAP Panel, 2012d), Technical guidance - Compatibility
of zootechnical microbial additives with other additives showing antimicrobial activity (EFSA, 2008b).
3. Assessment
3.1. Origin and extraction
Origanum is a genus of herbaceous plants belonging to the mint family (Lamiaceae), native to
Europe, North Africa and temperate areas of Asia. The genus contains a number of species widely
used for culinary purposes and as medicinal plants. The most commonly encountered are O. vulgare,
known as ‘oregano’ in most European countries, and Origanum majorana (sweet marjoram). The
related species Origanum onites (Pot marjoram or Turkish oregano) and Origanum syriacum (Syrian
oregano) are similarly used as culinary herbs and a source of ﬂavours. Cuban oregano also belongs to
the mint family but from another genus (Plectranthus ambonicus), while Mexican oregano
(Lippia graveolens) belongs to an entirely different plant family (Verbenaceae).
Five subspecies of O. vulgare are presently recognised of which the subspecies viridulum, viride and
hirtum are the most commonly found in Europe. The essential oil from the subspecies hirtum is
considered of particular quality and oils from this subspecies from different locations and varieties have
been extensively analysed. Analysis has shown that within this subspecies, two main chemotypes can
be recognised (carvacrol-rich or thymol-rich oils) together with intermediate types containing both
isomers and other types in which the precursors, p-cymene and c-terpinene, also are present in
signiﬁcant amounts (D’Antuono et al., 2000).
The essential oil is extracted from the leaves and shoots of the plant by steam distillation in yields
which typically vary between 0.4% to 1.2% dry matter (DM) but can be as high as 2.0%. Supercritical
ﬂuid extraction with CO2 may be used to limited extent.
3.2. Characterisation
3.2.1. Characterisation of the essential oil
This application concerns only the essential oil derived by steam distillation from a single registered
variety (Vulkan) of O. vulgare subsp. hirtum (Link) letsw. The product is a yellow-green to dark brown
clear liquid with a density of 0.935–0.950 g/cm3. The product speciﬁcations as proposed by the
applicant are based on the main components of the essential oil, namely carvacrol, thymol, c-
terpinene, p-cymene (also known as 1-isopropyl-4-methylbenzene), linalool, b-caryophyllene, a-
terpinene, terpinen-4-ol and trans-sabinene hydrate. Analysis of 11 batches of the additive6 showed
compliance with these speciﬁcations (Table 1). These nine compounds account for about 89.2% of the
product (expressed as area %).
6 Technical dossier/Supplementary information September 2016/SIn1_03.
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The applicant provided the full characterisation of ﬁve batches obtained by gas chromatography
(GC) coupled with a ﬂame ionisation detector and mass spectrometry.7 Besides the nine compounds
indicated in the product speciﬁcations, 25 other compounds have been identiﬁed and quantiﬁed in the
ﬁve batches and accounted on average for 99.06% (99.03–99.11%) of the product. Seven out of
these 25 compounds were > 0.5% and are listed in Table 2; the remaining 18 ranged between 0.05%
and 0.45% and are listed in the footnote.8
Table 1: Constituents of the essential oil from Origanum vulgare L. subsp. hirtum: speciﬁcations
and batch to batch variation based on 11 batches. The content of each constituent is
expressed as the area per cent of the corresponding chromatographic peak (% GC area),
assuming the sum of chromatographic areas of all detected peaks as 100%
Constituents CAS no FLAVIS no
Speciﬁcation
Analysis of 11 batches
(GC area %)
GC area % Mean Range
Carvacrol 499-75-20 04.031 60–65 61.06 60.07–61.85
Thymol 89-83-8 04.006 1.0–3.0 2.10 1.97–2.34
c-Terpinene 99-85-6 01.020 4.0–9.0 7.95 7.72–8.45
p-Cymene 99-87-6 01.002 5.0–10.0 8.77 8.38–9.10
Linalool 78-70-6 02.013 < 5.0 3.96 4.89–3.52
b-Caryophyllene 87-44-5 01.007 2.0–5.0 3.39 3.21–3.79
a-Terpinene 99-86-5 01.019 < 1.5 0.72 0.62–0.90
Terpinen-4-ol 562-74-3 02.072 < 2.0 0.80 0.71–0.85
trans-Sabinene hydrate 546-79-2 02.085 0.3–1.0 0.44 0.36–0.56
Total 89.2
CAS No: Chemical Abstract Service No.; FLAVIS number: EU Flavour Information System numbers; GC: gas chromatography.
Table 2: An extended analysis of the essential oil from Origanum vulgare L. subsp. hirtum based on
ﬁve batches, including the main components described in Table 1 and other seven
constituents above 0.5%. The remaining 18 compounds are listed in footnote8
Constituents CAS no FLAVIS no
Analysis of 5 batches
(GC area %)
Mean Range
Carvacrol 499-75-20 04.031 60.8 60.4–61.4
Thymol 89-83-8 04.006 2.26 2.1–2.4
c-Terpinene 99-85-6 01.020 7.62 7.1–7.8
p-Cymene 99-87-6 01.002 8.40 7.9–8.8
Linalool 78-70-6 02.013 3.82 3.7–4.0
b-Caryophyllene 87-44-5 01.007 3.56 3.4–3.7
a-Terpinene 99-86-5 01.019 0.60 0.60
terpinen-4-ol 562-74-3 02.072 0.80 0.80
trans-Sabinene hydrate 546-79-2 02.085 0.42 0.4–0.5
Pin-2(10)-ene (b-pinene) 127-91-3 01.003 1.02 1.02–1.02
d-Limonene 5989-27-5 01.045 0.82 0.79–0.85
1,8-Cineole (Eucalyptol) 470-82-6 03.001 1.57 1.52–1.59
Camphor 464-49-3 07.215 0.95 0.92–0.98
3,7,10-Humulatriene 6753-98-6 01.043 0.62 0.59–0.65
7 Technical dossier/Section II/Annex_II_3 and Annex_II_4.
8 Remaining compounds: sabinene, a-pinene, camphene, myrcene, a-phellandrene, octan-3-one, terpinolene, octan-3-ol, 1-
octene-3-ol, a-copaene, bornyl acetate, carvacryl methyl ether, b-bisabolene, d-cadinene, cumin aldehyde, a-calacorene,
caryophyllene oxide and eugenol.
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Twelve minor peaks detected in the chromatograms, accounting in total for 0.89–0.97% (0.94% on
average) of the total area, could not be identiﬁed.9
3.2.2. Impurities
Analysis of three batches found that the heavy metals (mercury, cadmium and lead) and arsenic were
not of concern. The sum of dioxins was 0.13 ng WHO PCDD/F-TEQ (World Health Organization
polychlorinated dibenzo-p-dioxin (PCDD) and polychlorinated dibenzofuran (PCDF) toxic equivalents)/kg
oil and dioxin-like PCBs was 0.08 ng WHO-PCDD/F-PCB-TEQ (World Health Organization PCDD, PCDF
and polychlorinated biphenyl (PCB) toxic equivalents)/kg oil. Organochloride, organophosphorous and
organonitrogen pesticides, halogen containing fungicides and pesticides, pyrethroids and pyrethrins and
nitrogen-containing herbicides could not be detected in any of the batches examined.10
3.2.3. Shelf-life
Three batches of the additive under application were stored in light-protected sealed containers at
ambient temperatures not falling below 12°C for periods of 35–50 months. Each batch was analysed
for the content of carvacrol, thymol, c-terpinene, p-cymene and linalool at the start and end of the
storage period. No changes in composition were observed supporting the declared shelf-life of
3 years.11 The applicant advises that storage temperature should not exceed 25°C.12
3.2.4. Conditions of use
The additive is intended for use in feed for all animal species at a concentration of 15–150 mg/kg
complete feed. No withdrawal period is foreseen.
These conditions of use were modiﬁed during the assessment for the dairy cow for which the
additive is intended to be given with a highest recommended dose of 500 mg/head and day
(equivalent to approximately 25 mg/kg complete feed).
3.3. Safety
3.3.1. Genotoxicity
No genotoxicity studies are available for the essential oil under application. As an alternative, the
FEEDAP Panel considered individually each of the component compounds identiﬁed. With two
exceptions, all of the identiﬁed compounds (34 compounds, listed in Table 2 and footnote 8) have
been assessed for use in food and are all currently listed in the European Union (EU) database of
ﬂavouring substances.13 For the two components not previously assessed for use in food, a-copaene,
and a-calacorene, a quantitative structure–activity relationship (QSAR) analysis (Toxtree) was made for
potential genotoxicity and mutagenicity. No alerts were identiﬁed.14
Constituents CAS no FLAVIS no
Analysis of 5 batches
(GC area %)
Mean Range
a-Terpineol 98-55-5 02.014 1.05 1.02–1.08
D,L-Borneol 507-70-0 02.016 1.59 1.55–1.64
Total 95.92
CAS No: Chemical Abstract Service No.; FLAVIS number: EU Flavour Information System numbers; GC: gas chromatography.
9 Technical dossier/Section II/Annex_II_4.
10 Technical dossier/Section II/Annex_II_18.
11 Technical dossier/Section II/Annexes_II_11, 12, 13.
12 Technical dossier/Section II/Annex_II_15.
13 Commission Implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of ﬂavouring substances provided
for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to Regulation (EC)
No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) No 1565/2000 and
Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p. 1.
14 Technical dossier/Section III/Annex_III_19.
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3.3.2. Safety for the target species
A total of ﬁve tolerance studies in three species (chickens for fattening, weaned piglets and dairy
cows) were made to assess the safety for the target species. The test preparation used in all studies
was a commercial formulation in powder form (DOSTO 500 concentrate) containing 50% of essential
oil under application, the remainder of the formulation being food-grade silicic acid (E551a).15 The
carvacrol content of the test preparation is approximately 31%.16 The amount of DOSTO 500
concentrate incorporated into feed, adjusted based on the analysis of the speciﬁc batch, was used to
deliver the stated amount of the essential oil (i.e. ~ 300 mg DOSTO 500 concentrate was used to
deliver 150 mg essential oil).
3.3.2.1. Safety for weaned piglets
Two trials of similar design were made, both measuring performance. In addition, gross pathology
was examined in the ﬁrst trial with tissue samples retained for examination of residues and in the
second trial haematology and blood chemistry were monitored.
In the ﬁrst trial, 128 piglets of unspeciﬁed breed (around 28 days of age, ~ 8.4 kg) were
distributed on the basis of body weight to one of four treatments. Each treatment had eight replicate
pens with four piglets per pen (two males and two females).17 Animals were given ad libitum a basal
mash diet based on wheat, oats, whey powder and full-fat soya either unsupplemented (control), or
supplemented with intended use level of 150 mg essential oil/kg feed (maximum use level), 450 mg
essential oil/kg feed (x3 maximum use level) or 750 mg essential oil/kg feed (x5 maximum use level).
However, analysis of feed based on the known carvacrol content of the test item gave recoveries
between approximately 65% and 86% of the expected value.18 The duration of the study was
42 days. Body weight and feed intake were measured daily, and from this data, total weight gain and
feed to gain ratio were calculated. After 42 days, two animals from control and two from the 150 mg
oil group were sacriﬁced and subjected to necropsy and gross pathology. At the same time, samples
from liver, abdominal fat and skeletal muscle were taken and frozen for analysis of residues.19 Data
was subjected to an analysis of variance with standard error of the means tested for signiﬁcance using
the pen as the experimental unit. Signiﬁcance was set at (p ≤ 0.05).
The second trial mirrored the conditions of the ﬁrst except the x3 treatment group was excluded,
leaving three treatments groups (0, x1 and x5 maximum use level). Pigs were housed in pairs (one
male and one female) and each treatment was replicated ten times, giving a total of 60 piglets.20 The
duration of the study also was 42 days and the same basal feed used. Body weight and feed intake
were measured daily, and from this data, total weight gain and feed to gain ratio were calculated.
After 42 days, blood samples were taken from all pigs. As previously, data was subjected to an
analysis of variance with standard error of the means tested for signiﬁcance. The pen was treated as
the experimental unit for the analysis of performance characteristics.
Animals remained in good health throughout the studies and no deaths were recorded. The
performance data for both trials are summarised in Table 3.
Table 3: Effect of the essential oil on zootechnical performance in piglets
Performance parameter
Essential oil (mg/kg feed)
0 150 450 750
Trial 1
Final body weight (kg) 35.1 34.7 34.5 36.6
Total weight gain (kg) 26.7 26.2 26.1 28.1
Total feed intake (kg) 51.8 50.9 50.6 53.9
Feed to gain 1.94(a) 1.94(a) 1.94(a) 1.92(b)
15 Technical dossier/Section II/Annex_II_20.
16 Technical dossier/Section III/Annex_III_4.
17 Technical dossier/Section III/Annex_III_7.
18 Technical dossier/Section III/Annexes_III_5 and 6.
19 Technical dossier/Section III/Annex_III_20.
20 Technical dossier/Section III/Annex_III_8.
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No adverse effects on performance were seen in either trial. Gross pathological observation of the
euthanised animals from the ﬁrst trial did not reveal any abnormalities. However, it should be noted
that this involved only two animals from the use level group and none from either of the overdose
groups.
Except a decrease in the monocytes numbers in both test groups (0.7 9 109/L) compared to the
control value (1.3 9 109/L), no signiﬁcant changes in haematology or clinical chemistry parameters
were observed in the second trial. The difference in monocyte numbers are considered to be without
pathological consequences and might have derived from the higher numbers in the control group.
3.3.2.2. Safety for chickens for fattening
The two trials made with chickens for fattening followed the same pattern as the piglet studies. In
both, performance parameters were measured. In addition, in the ﬁrst trial, a gross pathology
examination was made on a limited number of animals and tissue sample taken for residue
determination, while in the second blood samples were taken for haematology and clinical chemistry.
In the ﬁrst trial, a total of 1,680 one-day-old male Ross 308 broilers were distributed in groups of
35 birds to four dietary treatments (four treatments groups of 12 pens) for a period of 42 days.21 The
dietary treatments resulted from the supplementation of a pelleted wheat–soybean meal diet with the
essential oil at 0, 150, 300 or 600 mg/kg complete feed (conﬁrmed by the analysis of carvacrol).22
Body weight and feed intake were measured on days 0, 14 and 42, and from this data, body weight
gain and feed to gain ratio were calculated. Four birds from the control and four from the 150 mg oil
group were taken. A gross pathological examination was made and duplicate samples from fat,
skeletal muscle and liver retained for residue studies. Data was subjected to an analysis of variance
with standard error of the means tested for signiﬁcance using the pen as the experimental unit.
Signiﬁcance was set at (p ≤ 0.05).
The second study used the same dietary treatments as the ﬁrst, but involved only a total of 80
one- day-old male Ross 308 broilers. These were distributed in groups of two birds to four dietary
treatments, giving 10 replicates per treatment. As previously, the diets were analysed for carvacrol
content as conﬁrmation of use levels. The duration of the study was 35 days.23 Body weight and feed
intake were measured on days 0, 14 and 35, and from this data, weight gain and feed to gain ratio
were calculated. Blood samples were taken from all birds at the end of the trial. Data was analysed as
in the previous study with the pen used as experimental unit for the performance data (Table 4).
Performance parameter
Essential oil (mg/kg feed)
0 150 450 750
Trial 2
Final body weight (kg) 32.2 32.8 – 33.2
Total weight gain (kg) 22.0 22.7 23.2
Total feed intake (kg) 46.5 47.9 49.3
Feed to gain 2.12 2.11 2.13
(a), (b): Means within a column not sharing a common superscript are signiﬁcantly different (p < 0.05).
Table 4: Effect of the essential oil on zootechnical performance in chickens for fattening
Performance parameter
Essential oil (mg/kg feed)
0 150 300 600
Trial 1
Final body weight (kg) 2.91 2.90 2.89 2.83
Total weight gain (kg) 2.87 2.86 2.86 2.80
Total feed intake (kg) 4.99 4.94 4.93 5.00
Feed to gain 1.74(b) 1.72(c) 1.73(b),(c) 1.79(a)
21 Technical dossier/Section III/Annexes_III_09.
22 Technical dossier/Section III/Annexes_III_10-15.
23 Technical dossier/Section III/Annex_III_10.
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Overall mortality was 1.6% in the ﬁrst trial and not treatment related. There were no mortalities in
the second trial. The results showed no difference in the zootechnical parameters except a signiﬁcant
(p < 0.001) increase in the feed to gain ratio for the highest use level group compared to the control
in trial 1. Gross pathological observation of the euthanised animals from the ﬁrst trial did not reveal
any abnormalities. However, as in the pig studies, it should be noted that this involved only animals
from the use level group and none from either of the overdose groups. There were no signiﬁcant
differences detected in the haematology and clinical chemistry data.
3.3.2.3. Safety for dairy cows
A total of 72 Holstein cows were distributed to four treatment groups each of 18 animals. Animals
were assigned on the basis of a randomised complete block design with blocking by parity, calving date
and start of lactation. All animals were fed a total mixed ration (total mixed ration (TMR): 62.7% DM, net
energy of lactation (NEl) 1.53 Mcal/kg DM, crude protein (CP) 15.4% DM, neutral detergent ﬁber (NDF)
33.8% DM). The essential oil in the form of DOSTO 500 concentrate was diluted with a concentrate at
1% and added to the TMR to give 0, 500, 1,500 or 2,500 mg/head and day. Based on the data available,
the highest dose tested (2,500 mg/head and day) would equate to around 115 mg/kg complete feed
(88% DM). The content of carvacrol was analysed in the concentrate supplied to the control animals and
that given to the treatment groups.24 The lactating dairy cows (electronically tagged) were fed the TMR
for 57 days and feed offered and refused was recorded daily. Animals were weighed daily and individual
milk production and milk fat, protein and lactose were recorded after each milking. Somatic cell counts
were counted every 18 days in four consecutive milking. Duplicate samples of milk were taken from the
control and the recommended dose group at days 1, 28 and 56 for the analysis of residues and
metabolites derived from the essential oil. One sample from each treatment group was taken at the
beginning and at the end of the experiment to analyse the fatty acid proﬁle. Blood samples were taken
from ﬁve animals per treatment on days 1, 28 and 56.25
Data was analysed by a mixed-effects model for repeated measures. The model accounted for the
ﬁxed effects of treatment, week of study, parity (either primiparous or multiparous) plus the random
effects of animal within treatment. Week of study entered the model as a repeated measure using the
variance–covariance matrix that yielded the least Bayesian information criterion. Days in milk at the
beginning of the study entered the model as a covariate.
As expected, primiparous cows produced signiﬁcantly less (p < 0.01) milk (27.2  0.99 kg/day)
than multiparous cows (31.7  1.17 kg/day) but there were no differences between treatment groups.
Similarly, primiparous cows had a lesser milk fat content (3.58  0.06%) than multiparous cows
(3.82  0.07%), but there were no further differences due to treatment. Milk protein or lactose
concentration was unaffected by treatment or parity. There were also signiﬁcant differences
(p < 0.001) between the body weight of primiparous (643  9.8 kg) and multiparous (736  11.7 kg)
cows. But body weight/weight gain was unaffected by treatment. Similarly daily feed intake (22.5–22.9 kg)
and milk to feed ratio (1.27–1.30) was not signiﬁcantly affected by treatment.
No signiﬁcant treatment related effects were seen in clinical chemistry or haematological data.
3.3.2.4. Microbiological studies
The minimum inhibitory concentration (MIC) of a single batch of the additive under application26
was tested against a number of indicator strains of bacteria as recommended in the guidance on
Performance parameter
Essential oil (mg/kg feed)
0 150 300 600
Trial 2
Final body weight (kg) 2.14 2.19 2.18 2.17
Total weight gain (kg) 2.10 2.15 2.14 2.13
Total feed intake (kg) 3.49 3.51 3.51 3.52
Feed to gain 1.64 1.62 1.64 1.65
(a), (b), (c): Means within a column not sharing a common superscript are signiﬁcantly different (p < 0.5).
24 Technical dossier/Section III/Annex 11.
25 Technical dossier/Section III/Annex 16.
26 Technical dossier/Section III/Annex 22.
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microbial studies (EFSA, 2008b). A serial dilution of the additive in nutrient broth was prepared and
inoculated with the individual indicator strains. After 24 h, incubation the broth was plated onto solid
medium and any growth observed. Results for the indicator strains were Escherichia coli (American type
culture collection (ATCC) 25922) 0.3 mg/mL, Pseudomonas aeruginosa (ATCC 27853) 1 mg/mL,
Enterococcus faecalis (ATCC 29212) 0.5 mg/mL, Staphylococcus aureus (ATCC 25923) 0.5 mg/mL,
Bacillus subtilis (ATCC 6633) 50 mg/mL and an unspeciﬁed strain of E. coli 0157:H7 5 mg/mL. The
Guidance on compatibility indicates (EFSA, 2008b) that if a MIC value against a target organism is four
times greater than the use level in feed then compatibility can be conﬁrmed. As the maximum
recommended use level of 150 mg/kg feed is substantially higher than the MIC values determined for
some strains tested, effects on the gastrointestinal microﬂora cannot be excluded. However, there were
no indications in the tolerance studies of gastrointestinal disturbance.
3.3.2.5. Conclusions on safety for the target species
Chickens for fattening and weaned piglets showed no adverse effects when given feed containing the
additive under application up to four or ﬁve times the maximum recommended use level. Consequently,
the maximum recommended use level of 150 mg additive/kg feed is considered safe for these species
and categories. This conclusion is extended to all poultry and all porcine species/categories grown for
meat production at the same maximum use level, but excludes those used for reproduction.
The dairy cow is intended to be given the additive on a head and day basis with a highest
recommended dose of 500 mg additive/head and day. This is equivalent to ~ 25 mg/kg complete feed,
a value at the lower end of the range proposed for other species/categories. The results of the
tolerance study with dairy cows would support the safety of this dose.
Safety has been demonstrated in three major species with a comparable margin of safety between
the maximum proposed use level and the highest tolerated use level tested, allowing a conclusion on
safety to be extrapolated to all species. However, since the recommended use level differs between
the dairy cow and the non-ruminants tested, the lower use level of 25 mg additive/kg feed or, if
appropriate, the equivalent dose on a head and day basis is applied to all target species or categories
not included above.
3.3.3. Safety for the consumer
3.3.3.1. Toxicology
A subchronic 90-day oral toxicity rat study with the essential oil of O. vulgare has been published
(Llana-Ruiz-Cabello et al., 2017). Although the test item derived from another subspecies O. vulgare
subsp. virens (Hoffmanns & Link) letsw., analysis shows that it is similar in composition and content to
the essential oil under application (Table 5).
A total of 80 male and female Wistar rats were given 0, 50, 100 or 200 mg/kg body weight (bw) per
day via the diet for 90 days following the Organisation for Economic Co-operation and Development
(OECD) Guideline 408. Each treatment group consisted of 10 male and 10 female animals. Doses were
selected after an acute oral toxicity study in which rats were given 2,000 mg/kg bw by gavage which did
Table 5: Comparison of the test item used in the subchronic oral toxicity study (A) and the
essential oil under application (B)
Compound Essential oil A (%) Essential oil B (%)
Carvacrol 55.82 60.80
Thymol 5.14 2.26
c-Terpinene 4.71 7.62
p-Cymene 16.31 8.40
Linalool nr 3.82
b-Caryophyllene 2.40 3.56
a-Terpinene 1.62 0.60
Terpinen-4-ol 1.33 0.80
trans-Sabinene hydrate nr 0.42
Total 87.3 88.3
Nr: not reported.
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not result in the death of any animal and a palatability study which indicated that a dose greater than
200 mg/kg bw per day was likely to result in feed refusal. There were no deaths in the study and no
signiﬁcant differences in growth between groups. The results of haematology, blood chemistry, gross
pathology and histology showed no evidence of any treatment related adverse effects. Consequently, a
no observed adverse effect level (NOAEL) of 200 mg/kg bw per day, the top dose tested, was identiﬁed.
3.3.3.2. Residue studies
Residue studies were made with chickens for fattening, laying hens, piglets and dairy cows.
Appropriate tissue/products from animals fed a basal diet or one supplemented with the additive under
application at the maximum recommended level were analysed for carvacrol and its isomer thymol, which
collectively represent approximately 65% of the essential oil. Analysis was carried out using gas
chromatography/mass spectrometry (GC/MS) with a limit of quantitation (LOQ) of 3 lg/kg tissue
(Table 6).
To assess the concentration of possible residues in eggs, laying hens (Lohmann Brown classic) were
fed with standard basal diet or standard basal diet supplemented with the additive 150 mg/kg feed for
28 days. After reaching the metabolic steady state (day 28), 10 eggs were taken from 10 birds from
each group on three consecutive days. Eggs were cracked and immediately frozen. Two eggs per day
and per group (n = 6) were analysed for carvacrol and thymol (LOQ 3 lg/kg). No monoterpene was
detected in eggs from the control group. Thymol was not detected in eggs from the supplemented
group, but a trace amount of carvacrol (mean 4.7 lg/kg) was found.27
From the tolerance study made with dairy cows, duplicate milk samples were taken on days 1, 28
and 56 from ﬁve animals from the control group and ﬁve from the group given the additive at the
maximum recommended dose. Trace amounts of both carvacrol and thymol below the LOQ (8.1 lg/L)
could be detected in all samples.28
3.3.3.3. Consumer exposure
Carvacrol and thymol are taken as marker compounds. The highest residue values were found for
carvacrol in pig tissues. However not all tissues were examined and, with only two animals, it is not
possible to derive a standard deviation. Nonetheless applying the available mean data to the Joint FAO/
WHO Expert Committee on Food Additives (JECFA) food basket,29 as described in the guidance on
consumer safety (EFSA FEEDAP Panel, 2012c), gives an estimated daily exposure from pig tissues of
approximately 50 lg carvacrol. Additional exposure from milk/eggs would make a negligible contribution.
This estimated exposure can be related to a daily safe exposure of 1,800 lg carvacrol/person and day,
the value derived from an assessment based on the threshold of toxicological concern (TTC) for this
Cramer class I compound. The estimate for thymol would result in a 10-fold lower value (5 lg thymol).
Table 6: Carvacrol and thymol content (lg/kg) of tissues from chickens for fattening and piglets
given a basal diet free from the essential oil or a diet supplemented with 150 mg
additive/kg feed
Tissue Control feed Origanum supplemented diet
Thymol Carvacrol Thymol Carvacrol
Chickens for fattening (n = 4)
Fat nd nd 6.8 63.1
Liver nd nd 6.5 97.4
Skeletal muscle nd nd 8.0 42.0
Piglets (n = 2)
Fat nd nd 5.6 120.4
Liver nd nd 32.3 316.1
Skeletal muscle nd nd 4.7 39.6
nd: not detected (LOQ 3 lg/kg, LOD not given).
27 Technical dossier/Supplementary information_September 2016/Annex Sin1_02.
28 Technical dossier/Section III/Annex_III_21.
29 Default daily adult human consumption ﬁgures according to Regulation (EC) No 429/2008: 300 g meat, 100 g liver, 50 g
kidney and 50 g fat.
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The other compounds identiﬁed in the essential oil are terpenoids (see Table 2 and footnote 8) with
metabolisms similar to that shown by carvacrol. Since they occur in substantially lower concentrations
than carvacrol, they are not expected to be individually detected in anything other than trace amounts
in tissues and products and not to modify the conclusion on consumer safety derived from the study of
carvacrol and thymol.
Support for this conclusion is provided by the oral toxicity study made with an essential oil of
similar composition to that under application from which a NOAEL of 200 mg/kg bw per day (the
upper dose tested) was derived (Llana-Ruiz-Cabello et al., 2017). Compared to the 50 lg carvacrol
exposure, which represents over 60% of the extract, the margin of exposure would be 4,000.
3.3.3.4. Conclusions on safety for the consumer
No concerns for consumer safety were identiﬁed following the application of the additive at the
proposed use level in animal nutrition.
3.3.4. Safety for the user30
A test of acute dermal toxicity of the additive was made following OECD 402 guideline,31 which
indicates that the LD50 for the essential oil under test is > 2,000 mg/kg bw. Although not the purpose
of the study, the observations of the study point to a potential for skin (and eye) irritation. This was
recognised by the applicant who indicated the hazard statements H315 and H319 in the safety data
sheet.
No studies relating to sensitisation were provided. However, there are occasional reports of
exposure to oregano and its extracts within the workplace and outside resulting in respiratory and skin
disorders included allergic reactions (Campiglio et al., 1983; Futrell and Rietschel, 1993). It has also
been noted that plants belonging to the Labiatae can induce cross-sensitivity in humans (Benito et al.,
1996).
3.3.4.1. Conclusions on safety for the user
The additive should be considered as irritant to skin and eyes and a potential skin and respiratory
sensitiser in susceptible individuals.
3.3.5. Safety for the environment
Origanum vulgare is a native species to Europe where it is widely grown both for commercial and
decorative purposes. The oil content of oregano varies from 4,000 to 20,000 mg oil/kg oregano. The
maximum concentration of the oil is 150 mg/kg feed. This amount is not likely to change the
concentration of compounds from oregano oil in the environment. Use of the essential oil extracted
from the plant in animal production is not expected to pose a risk for the terrestrial or fresh water
environment.
3.4. Efﬁcacy
Under the terms Regulation (EC) No 1334/2008 ﬂavouring preparations produced from food, may
be used without an evaluation and approval as long as ‘they do not, on the basis of the scientiﬁc
evidence available, pose a safety risk to the health of the consumer, and their use does not mislead
the consumer’. Consequently, there is no speciﬁc EU authorisation for any Origanum vulgare extract
when used to provide ﬂavour in food. However, oregano and its extracts are listed in Fenaroli’s
Handbook of Flavour Ingredients (Burdock, 2009a) and by the Flavour and Extract Manufactures
Association (FEMA) with the reference number 2828.
Since oregano and its extracts is universally recognised to ﬂavour food and its function in feed would
be essentially the same as that in food, no further demonstration of efﬁcacy is considered necessary.
The applicant makes reference to two studies considering possible changes in the sensory
properties of animal products following the use of the additive. However, the ﬁrst of these on egg
quality was not further considered as the use level of the essential oil used (12.5 mg additive/kg feed)
was below the minimum use level described under conditions of use.
In the second study, milk samples generated in the tolerance study with dairy cows (see
Section 3.3.2.3) were taken on day 0 and day 56 from four cows of each of the four treatments and
30 This section has been amended according to the conﬁdentiality claim made by the applicant.
31 Technical dossier/Section III/Annex 24.
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the fatty acid composition of each sample determined. The results showed that supplementation with
the additive under application up to 2,500 mg/head and day did not alter the pattern of fatty acids
present in the milk.
4. Conclusions
The recommended use level of 150 mg additive/kg feed is considered safe for chickens for fattening
and weaned piglets. This conclusion is extended to all poultry and all porcine species/categories grown
for meat production at the same maximum use level, but excludes those used for reproduction. The
recommended dose of 500 mg additive/head and day (equivalent to ~ 25 mg/kg complete feed) is also
demonstrated safe for the dairy cow. Since the recommended use level differs between the dairy cow
and the non-ruminants tested, the lower use level of 25 mg additive/kg feed or, if appropriate, the
equivalent dose on a head and day basis, is applied to all target species or categories not included above.
No concerns for consumer safety were identiﬁed following the application of the additive at the
maximum proposed use level in animal nutrition.
The additive should be considered as an irritant to skin and eyes and a potential skin and
respiratory sensitiser in susceptible individuals.
Use in animal production of the essential oil extracted from O. vulgare is not expected to pose a
risk for the terrestrial or fresh water environment.
Since oregano and its extracts is recognised to ﬂavour food and its function in feed would be
essentially the same as that in food, no further demonstration of efﬁcacy is considered necessary for
the essential oil.
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ATCC American type culture collection
bw body weight
CAS Chemical Abstracts Service
CP crude protein
DM dry matter
EURL European Union Reference Laboratory
FAO Food and Agriculture Organization
FEEDAP EFSA Scientiﬁc Panel on Additives and Products or Substances used in Animal Feed
FEMA Flavour and Extract Manufactures Association
FID ﬂame ionisation detector
FLAVIS the EU Flavour Information System
GC gas chromatography
GC/MS gas chromatography/mass spectrometry
JECFA The Joint FAO/WHO Expert Committee on Food Additives
LOD limit of detection
LOQ limit of quantitation
MIC minimum inhibitory concentration
NDF neutral detergent ﬁber
NEl net energy of lactation
NOAEL no observed adverse effect level
OECD Organisation for Economic Co-operation and Development
PCB polychlorinated biphenyl
PCDD polychlorinated dibenzo-p-dioxin
PCDD/F polychlorinated dibenzo-p-dioxin and polychlorinated dibenzofuran
PCDF polychlorinated dibenzofuran
QSAR quantitative structure-activity relationship
TEQ toxic equivalents
TMR total mixed ration
TTC threshold of toxicological concern
WHO World Health Organization
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for oregano essential oil
In the current application, authorisation is sought under article 4(1) for natural essential oil from
Origanum vulgare L., subsp. hirtum var. Vulkan (DOS 00001) under the category/functional group 2(b)
‘Sensory additives’/ ‘ﬂavouring compounds’ according to the classiﬁcation system of Annex I of
Regulation (EC) No 1831/2003. Speciﬁcally, authorisation is sought for the use of the feed additive for
all animal species and categories.
The Applicant deﬁned the product as ‘natural essential oil from Origanum vulgare L. subsp. hirtum
var. Vulkan (DOS 00001)’, containing the following main constituents: Carvacrol (60–65%); p-Cymene
(5–10%); c-Terpinene (4–9%); b-Caryophyllene (2.0–5.0%); Thymol (1.0–3.5%); Linalool (less than
5.0%); a-Terpinene and Terpinen-4-ol (less than 2.0% each). The Applicant suggested using Carvacrol
as the phytochemical marker. The feed additive is to be used in feedingstuffs with no proposed
minimum or maximum concentration levels. However, recommended inclusion levels of the feed
additive are ranging from 15 to 150 mg/kg complete feedingstuffs.
For the characterisation of the feed additive, the Applicant submitted a gas chromatography
coupled with ﬂame ionisation and mass spectrometric detection (GC-FID/MS) method – derived from
the ISO 11024 and the European Pharmacopoeia monograph 8.0, 2.2.28 – to identify and quantify the
main constituents. The Applicant reported a relative standard deviation for intermediate precision
(RSDip), ranging from 0.8% to 6.1% when quantifying Carvacrol and Thymol in the pure essential oil.
Based on the experimental evidence provided the EURL recommends the GC-FID/MS method for
ofﬁcial control to identify the major constituents and quantify the phytochemical marker (Carvacrol), in
the feed additive.
For the quantiﬁcation of Oregano essential oil in premixtures the Applicant submitted a method
based on volumetric analysis after water-steam distillation – derived from the ISO 6571 standard and
European Pharmacopeia monograph 8.0, 2.8.12. The Applicant applied this method for the analysis of
the essential oil in three different types of premixtures containing the essential oil on silica and fatty
plant oil carriers and reported satisfactory recovery rates (Rrec) ranging from 89.7% to 90.9% for the
volatile oil content. As for the feed additive, the EURL suggests applying the GC-FID/MS for the
identiﬁcation of the obtained essential oil. Based on the experimental evidence available, the EURL
considers these methods suitable for determination of oregano essential oil in the premixtures
investigated.
The accurate quantiﬁcation of added essential oil from Origanum vulgare L. subsp. hirtum var.
Vulkan (DOS 00001) in feedingstuffs is not achievable experimentally. Therefore, the EURL cannot
evaluate nor recommend any method for ofﬁcial control to quantify Origanum vulgare L. subsp. hirtum
var. Vulkan (DOS 00001) in feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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